Use of direct oral anticoagulants in antiphospholipid syndrome: Reply

被引：4
|
作者：
Cohen, Hannah [1 ,2 ]
Efthymiou, Maria [2 ]
Isenberg, David A. [3 ,4 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England
[2] UCL, Dept Haematol, Haemostasis Res Unit, 1st Floor,51 Chenies Mews, London WC1E 6HX, England
[3] UCL, Ctr Rheumatol, Div Med, London, England
[4] Univ Coll London Hosp NHS Fdn Trust, Dept Rheumatol, London, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2020年 / 18卷 / 01期
关键词：
antiphospholipid syndrome; arterial thrombosis; direct oral anticoagulants; triple positive antiphospholipid antibodies; venous thromboembolism; vitamin K antagonists'; ED AMERICAN-COLLEGE; ANTITHROMBOTIC THERAPY; PREVENTION; MANAGEMENT; THROMBOSIS;
D O I：
10.1111/jth.14674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 261
页数：3
相关论文
共 50 条
  • [1] The Use of Direct Oral Anticoagulants in Antiphospholipid Syndrome
    Kessler, Craig M.
    Cohen, Hannah
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 19 - 23
  • [2] Use of direct oral anticoagulants in antiphospholipid syndrome
    Cohen, H.
    Efthymiou, M.
    Isenberg, D. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (06) : 1028 - 1039
  • [3] Direct oral anticoagulants in antiphospholipid syndrome
    de Carvalho, Jozelio Freire
    Oliveira de Andrade, Daniele Castro
    Levy, Roger A.
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2016, 56 (06) : 469 - 470
  • [4] The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome
    Malec, Katarzyna
    Goralczyk, Tadeusz
    Undas, Anetta
    THROMBOSIS RESEARCH, 2017, 152 : 93 - 97
  • [5] Dosing considerations in the use of the direct oral anticoagulants in the antiphospholipid syndrome
    Schofield, J. R.
    Hassell, K.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (01) : 104 - 106
  • [6] Antiphospholipid syndrome and challenges with direct oral anticoagulants
    Booth, Stephen
    Burton, Kieran
    Hunt, Beverley
    Desborough, Michael
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2020, 81 (05)
  • [7] Direct Oral Anticoagulants (DOAC) in Antiphospholipid Syndrome?
    Specker, C.
    Doerner, T.
    Schneider, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (06): : 493 - 494
  • [8] The Role of Direct Oral Anticoagulants in Antiphospholipid Syndrome
    Alsheef, Mohammed Abdullah
    Alomar, Mukhtar
    Alarfaj, Ohoud
    AlHamidi, Hussam A.
    Zaidi, Abdul Rehman Z.
    BLOOD, 2019, 134
  • [9] Treatment of the antiphospholipid syndrome with direct oral - anticoagulants
    Bauersachs, R.
    Schellong, S.
    Stuecker, M.
    Oldenburg, J.
    Kalka, C.
    Scholz, U.
    Lindhoff-Last, E.
    PHLEBOLOGIE, 2019, 48 (04) : 271 - 274
  • [10] Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome"
    Yazici, Ayten
    Unlu, Ozan
    Erkan, Doruk
    THROMBOSIS RESEARCH, 2017, 157 : 82 - 83
12345